![](/images/graphics-bg.png)
Level of Adherence to Prophylactic Osteoporosis Medication amongst Patients with Polymyalgia Rheumatica and Giant Cell Arteritis: A Cross-Sectional Study
Joint Authors
Emamifar, A.
Gildberg-Mortensen, Rannveig
Lomborg, N.
Asmussen Andreasen, R.
Jensen Hansen, I. M.
Just, Søren Andreas
Source
International Journal of Rheumatology
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-5, 5 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-09-29
Country of Publication
Egypt
No. of Pages
5
Main Subjects
Abstract EN
Objective.
To estimate level of adherence to oral calcium and vitamin D supplementation as well as bisphosphonate amongst patients with PMR and GCA treated with glucocorticoids.
Method.
A total of 138 patients with the diagnosis of PMR and/or GCA registered in our department in December 2013.
In this cross-sectional study we interviewed all the patients to measure level of adherence to calcium and vitamin D, as well as bisphosphonates.
Results.
Out of the 118 included patients, 88.9% of them were adherent to their prescription.
Only 2 patients (1.7%) did not take calcium and vitamin D at all and 10 patients (8.5%) took their medication infrequently, 9 and 1 out of 10 patients took the medication 50–100% of the time and less than 50% of the prescribed dose, respectively.
Sixty-one patients received additional treatment with bisphosphonate and 96.6% were adherent to this therapy.
The remaining 3.4% of the patients did not take the medication at all.
Forgetfulness, adverse side effects, and lack of understanding of treatment benefits were the most significant causes for nonadherence to calcium and vitamin D.
Conclusions.
Contrary to what we expected this study found that adherence to osteoporosis preventive medication in patients with PMR and GCA was high.
American Psychological Association (APA)
Emamifar, A.& Gildberg-Mortensen, Rannveig& Just, Søren Andreas& Lomborg, N.& Asmussen Andreasen, R.& Jensen Hansen, I. M.. 2015. Level of Adherence to Prophylactic Osteoporosis Medication amongst Patients with Polymyalgia Rheumatica and Giant Cell Arteritis: A Cross-Sectional Study. International Journal of Rheumatology،Vol. 2015, no. 2015, pp.1-5.
https://search.emarefa.net/detail/BIM-1066893
Modern Language Association (MLA)
Emamifar, A.…[et al.]. Level of Adherence to Prophylactic Osteoporosis Medication amongst Patients with Polymyalgia Rheumatica and Giant Cell Arteritis: A Cross-Sectional Study. International Journal of Rheumatology No. 2015 (2015), pp.1-5.
https://search.emarefa.net/detail/BIM-1066893
American Medical Association (AMA)
Emamifar, A.& Gildberg-Mortensen, Rannveig& Just, Søren Andreas& Lomborg, N.& Asmussen Andreasen, R.& Jensen Hansen, I. M.. Level of Adherence to Prophylactic Osteoporosis Medication amongst Patients with Polymyalgia Rheumatica and Giant Cell Arteritis: A Cross-Sectional Study. International Journal of Rheumatology. 2015. Vol. 2015, no. 2015, pp.1-5.
https://search.emarefa.net/detail/BIM-1066893
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1066893